FR2453643A2 - Compositions pharmaceutiques actives sur le systeme nerveux central - Google Patents

Compositions pharmaceutiques actives sur le systeme nerveux central

Info

Publication number
FR2453643A2
FR2453643A2 FR7719390A FR7719390A FR2453643A2 FR 2453643 A2 FR2453643 A2 FR 2453643A2 FR 7719390 A FR7719390 A FR 7719390A FR 7719390 A FR7719390 A FR 7719390A FR 2453643 A2 FR2453643 A2 FR 2453643A2
Authority
FR
France
Prior art keywords
pharmaceutical compositions
nervous system
central nervous
derivatives
symbols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7719390A
Other languages
English (en)
Other versions
FR2453643B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7719390A priority Critical patent/FR2453643A2/fr
Priority to IL52550A priority patent/IL52550A/xx
Priority to NZ184666A priority patent/NZ184666A/xx
Priority to SE7708349A priority patent/SE7708349L/
Priority to GB30355/77A priority patent/GB1556567A/en
Priority to CA283,049A priority patent/CA1077846A/fr
Priority to LU77796A priority patent/LU77796A1/xx
Priority to IE1509/77A priority patent/IE45454B1/en
Priority to DE19772732614 priority patent/DE2732614A1/de
Priority to AU27151/77A priority patent/AU508753B2/en
Priority to NL7708055A priority patent/NL7708055A/xx
Priority to JP8785277A priority patent/JPS5326327A/ja
Priority to CH892677A priority patent/CH625122A5/fr
Priority to IT24866/78A priority patent/IT1096804B/it
Publication of FR2453643A2 publication Critical patent/FR2453643A2/fr
Application granted granted Critical
Publication of FR2453643B2 publication Critical patent/FR2453643B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSITION PHARMACEUTIQUE CONTENANT UN NEUROLEPTIQUE ET UN COMPOSE GABAMIMETIQUE, ACTIVE SUR LE SYSTEME NERVEUX CENTRAL.
FR7719390A 1976-07-20 1977-06-24 Compositions pharmaceutiques actives sur le systeme nerveux central Granted FR2453643A2 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR7719390A FR2453643A2 (fr) 1977-06-24 1977-06-24 Compositions pharmaceutiques actives sur le systeme nerveux central
NZ184666A NZ184666A (en) 1976-07-20 1977-07-18 Pharmaceutical compositions comprising a gabamimetic compound and a neuroleptic compound
IL52550A IL52550A (en) 1976-07-20 1977-07-18 Pharmaceutical compositions having an action on the central nervous system coprising a gabamimetic compound and a neuroleptic compound
LU77796A LU77796A1 (fr) 1976-07-20 1977-07-19
GB30355/77A GB1556567A (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system
CA283,049A CA1077846A (fr) 1976-07-20 1977-07-19 Compose pharmaceutique ayant une action sur le systeme nerveux central
SE7708349A SE7708349L (sv) 1976-07-20 1977-07-19 Farmaceutiska kompositioner och forfarande for framstellning derav
IE1509/77A IE45454B1 (en) 1976-07-20 1977-07-19 Pharmaceutical compositions having an action on the central nervous system
DE19772732614 DE2732614A1 (de) 1976-07-20 1977-07-19 Arzneimittel mit wirkung auf das zentralnervensystem
AU27151/77A AU508753B2 (en) 1976-07-20 1977-07-19 Central nervous system pharmaceuticals
JP8785277A JPS5326327A (en) 1976-07-20 1977-07-20 Medical composition active to central nerve system
NL7708055A NL7708055A (nl) 1976-07-20 1977-07-20 Werkwijze voor het bereiden van een geneesmid- del en zo gevormd geneesmiddel.
CH892677A CH625122A5 (en) 1977-06-24 1978-01-01 Pharmaceutical compositions with an action on the central nervous system
IT24866/78A IT1096804B (it) 1977-06-24 1978-06-22 Composizioni farmaceutiche attive sul sistema nervoso centrale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7719390A FR2453643A2 (fr) 1977-06-24 1977-06-24 Compositions pharmaceutiques actives sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
FR2453643A2 true FR2453643A2 (fr) 1980-11-07
FR2453643B2 FR2453643B2 (fr) 1984-10-12

Family

ID=9192520

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7719390A Granted FR2453643A2 (fr) 1976-07-20 1977-06-24 Compositions pharmaceutiques actives sur le systeme nerveux central

Country Status (3)

Country Link
CH (1) CH625122A5 (fr)
FR (1) FR2453643A2 (fr)
IT (1) IT1096804B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061234A1 (fr) * 1999-04-09 2000-10-19 Warner-Lambert Company Combinaisons d'analogues d'acide glutamique et d'acide gamma-aminobutyrique (gaba) et de composes tricycliques permettant de traiter la depression

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947579A (en) * 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
US3978216A (en) * 1974-06-03 1976-08-31 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US4129652A (en) * 1976-08-16 1978-12-12 Nelson Research & Development Company Method for potentiating neuroleptic drugs
US4138484A (en) * 1976-08-16 1979-02-06 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947579A (en) * 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
US3978216A (en) * 1974-06-03 1976-08-31 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US4129652A (en) * 1976-08-16 1978-12-12 Nelson Research & Development Company Method for potentiating neuroleptic drugs
US4138484A (en) * 1976-08-16 1979-02-06 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061234A1 (fr) * 1999-04-09 2000-10-19 Warner-Lambert Company Combinaisons d'analogues d'acide glutamique et d'acide gamma-aminobutyrique (gaba) et de composes tricycliques permettant de traiter la depression

Also Published As

Publication number Publication date
FR2453643B2 (fr) 1984-10-12
IT7824866A0 (it) 1978-06-22
IT1096804B (it) 1985-08-26
CH625122A5 (en) 1981-09-15

Similar Documents

Publication Publication Date Title
SE8700498D0 (sv) Novel pharmaceologically active compounds
NZ189418A (en) Propanolamine and morpholine derivatives pharmaceutical compositions
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
NO306344B1 (no) Nye sulfonamider, anvendelse derav og farmasöytiske preparater inneholdende dem
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ATE230723T1 (de) N-(2-aryl-propionyl)sulfonamide und sie enthaltende pharmazeutische zubereitungen
DE69113057T2 (de) Aniontenside, polyhydroxyfettsäureamide und magnesium enthaltende waschmittelzusammensetzungen.
NO179867C (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FI964772A0 (fi) (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa
DE69531098D1 (de) Piperidine und pyrrolidine
EA199900645A1 (ru) Композиции для лечения распираторного дистресс-синдрома взрослых или респираторного дистресс-синдрома новорожденных, содержащие 3-(циклопропилметокси)-n-(3,5-дихлор-4-пиридинил)-4-(дифторметокси) бензамид и легочное поверхностно-активное вещество
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DE60037813D1 (de) Antworten auf hypoxia modifizieren
NL7410989A (nl) N-(1-(epsilon-fenylalkyl)-piperidyl-4)-n-((alpha)-py- ridyl)-carbonzuuramiden, de zuuradditiezouten daarvan, de werkwijze voor de bereiding van deze stoffen, alsmede de toepassing daarvan als geneesmiddel.
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DE69733843D1 (de) Zusammensetzungen und verwendungvon benzamiden als entzuendungshemmende mittel
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DK0882033T3 (da) Benzofuran-acrylsyrederivater og deres anvendelse som modulatorer for RXRS- eller RARS-receptorer
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
DE69414194D1 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
ES2039267T3 (es) Dihidropiridinamidas, procedimiento para su preparacion y su empleo en medicamentos.
FR2453643A2 (fr) Compositions pharmaceutiques actives sur le systeme nerveux central
FR2387221A1 (fr) Derives du benzimidazole utilisables comme substances actives de medicaments veterinaires